Marker Therapeutics, Inc. — Director's Dealing 2004

Feb 17, 2004

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: GENEMAX CORP (GMXX)
CIK: 0001094038
Period of Report: 2003-12-31

Reporting Person: GENEMAX CORP (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2003-12-31	Common Stock $0.001 par value	A	0	—	Acquired	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2002-12-06	Stock Options	$1.15	A	100000	Acquired	2005-12-07	Common Stock (100000)	Direct
2003-12-16	Stock Options	$0.50	A	200000	Acquired	2011-12-16	Common Stock (200000)	Direct

Footnotes

F1: The Stock Options were originally granted to Mr. Hellstrom at an exercise price of $8.50, which exercise price was re-priced to $1.15 by the Board of Directors. As of December 31, 2003 75,000 stock options have vested and the remaining stock options will vest over the next twelve months.

F2: Granted in accordance with the terms and provisions of the Stock Option Plan dated December 16, 2003, in consideration of services and duties performed.